MENU
+Compare
CYYNF
Stock ticker: OTC
AS OF
Aug 8 closing price
Price
$0.12
Change
+$0.02 (+20.00%)
Capitalization
28.86M

CYYNF Cynata Therapeutics Ltd. Forecast, Technical & Fundamental Analysis

Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus... Show more

CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CYYNF with price predictions
Aug 15, 2025

CYYNF's RSI Oscillator stays in overbought zone for 13 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for CYYNF entered a downward trend on July 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

CYYNF moved above its 50-day moving average on August 04, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CYYNF crossed bullishly above the 50-day moving average on August 08, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 9 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.544) is normal, around the industry mean (19.433). P/E Ratio (0.000) is within average values for comparable stocks, (50.965). CYYNF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.945). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (301.042).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CYYNF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CYYNF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CYYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
100 Cubitt Street
Phone
+61 370676940
Employees
2
Web
https://www.cynata.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NESRF11.900.14
+1.19%
Northern Star Resources Ltd
ABTZY5.64N/A
N/A
Aboitiz Equity Ventures, Inc.
BGOUF2.17N/A
N/A
Bang & Olufsen AS
CPROF1.21N/A
N/A
Cortelco Systems Puerto Rico Inc.
NCXS61.00N/A
N/A
NBC Bancorp, Inc.

CYYNF and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with CADL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then CADL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYYNF
1D Price
Change %
CYYNF100%
N/A
CADL - CYYNF
46%
Loosely correlated
+0.83%
URGN - CYYNF
38%
Loosely correlated
-1.84%
MLLCF - CYYNF
31%
Poorly correlated
N/A
INKT - CYYNF
27%
Poorly correlated
-2.68%
BRTX - CYYNF
26%
Poorly correlated
+1.33%
More